Diagnostics News and Research

RSS

PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend

PerkinElmer today announced it has completed its acquisition of BioLegend, a leading, worldwide provider of life science antibodies and reagents.

From Revvity 22 Sep 2021

Research highlights potentially life-saving screening for HR-HPV–driven head and neck cancers

Cancer causing high-risk human papillomaviruses (HR-HPV) are responsible for the rising incidence of HR-HPV–driven head and neck cancers (HNC), particularly oropharyngeal cancers (OPC, or throat cancers). Investigators have determined that HR-HPV DNA can be detected in saliva in most patients with HPV-driven OPC at the time of diagnosis. This work highlights a potentially life-saving screening program based on salivary HR-HPV DNA testing for early cancer detection and patient monitoring. Their findings appear in The Journal of Molecular Diagnostics, published by Elsevier.

22 Sep 2021

Study findings could lead to novel ways to overcome tumor resistance to immunotherapies

Cancer-fighting immune cells in patients with lung cancer whose tumors do not respond to immunotherapies appear to be running on a different "program" that makes them less effective than immune cells in patients whose cancers respond to these immune treatments, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer Center Bloomberg~Kimmel Institute for Cancer Immunotherapy.

22 Sep 2021

Oxford COVID vaccine technology has the potential to revolutionize cancer treatment

Scientists from the University of Oxford and the Ludwig Institute for Cancer Research are building on the success of the Oxford-AstraZeneca vaccine against SARS-CoV-2 to develop a vaccine to treat cancer.

21 Sep 2021

International organizations, vaccine manufacturers discuss strategies to improve access to COVID-19 vaccines

The heads of the International Monetary Fund, World Bank Group, World Health Organization and World Trade Organization met with the CEOs of leading vaccine manufacturing companies to discuss strategies to improve the access to COVID-19 vaccines, especially in low- and lower middle-income countries and in Africa.

20 Sep 2021

AI can help with the diagnosis of B-cell lymphomas and related leukemias

The presence of cancer of the lymphatic system is often determined by analyzing samples from the blood or bone marrow.

18 Sep 2021

Two-hour glucose tolerance test helps identify patients at heightened risk of cognitive decline

Diabetes is a risk factor for cognitive decline. In a study of the University of Turku and Finnish Institute for Health and Welfare, the researchers observed that already a higher two-hour glucose level in the glucose tolerance test predicts worse performance in a test measuring episodic memory after ten years.

18 Sep 2021

Owlstone Medical appoints Mark Capone to board of directors

Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the appointment of Mark Capone, former President and CEO of Myriad Genetics to its Board as an independent non-executive director.

From Owlstone Medical Ltd 17 Sep 2021

Multiple sclerosis patients elicit robust T-cell responses to mRNA COVID-19 vaccines

New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment – which depletes the B cells that contribute to the MS attacks – are able to mount robust T-cell responses to the mRNA COVID-19 vaccines, despite having a muted antibody response to the vaccines.

17 Sep 2021

Improving optical tissue clearing method for better cancer diagnosis

When it comes to cancer, clarity is key. The ability to visualize cancerous tumors and metastatic tissue three dimensionally (3D) can help clinicians diagnose the precise type and stage of cancer, while also informing the best treatment methods.

16 Sep 2021

Study identifies factors that may influence patient's likelihood to get bariatric surgeries

According to the World Health Organization, four million people die from obesity-related causes annually. Studies have shown that bariatric surgery is an effective, lifesaving intervention for patients with obesity, however the majority who are eligible for the procedure never advance to surgery.

16 Sep 2021

Diagnostics News and Research

PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend

Research highlights potentially life-saving screening for HR-HPV–driven head and neck cancers

Study findings could lead to novel ways to overcome tumor resistance to immunotherapies

Oxford COVID vaccine technology has the potential to revolutionize cancer treatment

International organizations, vaccine manufacturers discuss strategies to improve access to COVID-19 vaccines

AI can help with the diagnosis of B-cell lymphomas and related leukemias

Two-hour glucose tolerance test helps identify patients at heightened risk of cognitive decline

Owlstone Medical appoints Mark Capone to board of directors

Multiple sclerosis patients elicit robust T-cell responses to mRNA COVID-19 vaccines

Improving optical tissue clearing method for better cancer diagnosis

Study identifies factors that may influence patient's likelihood to get bariatric surgeries

Genetic capacity of the gut microbiome determines weight loss success or failure

Severe COVID-19 linked to increase in autoantibodies

Colorectal Cancer Project launches to improve understanding of the disease and accelerate research

Health leaders issue an urgent call for vaccine equity globally and in Africa

CRG launches Europe's first continent-wide PhD training program for medical doctors

Does Delta increase the risk of hospitalization compared with Alpha?

Survey: Nearly two-thirds of thoracic oncologists used telehealth for the first time during pandemic

Microscopy paired with AI leads to a fast, accurate, and cost-effective COVID-19 test

New statement on COVAX global supply forecast for 2021 and early 2022

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News